It is our great pleasure to welcome you to the 30th Edition of the Porto Cancer Meeting. This renowned international meeting has been organized since 1990 by Ipatimup and is now a flagship meeting of i3S – Institute for Research and Innovation in Health – the largest health research institute in Portugal. This year, the scientific program of the 30th Porto Cancer Meeting will focus on RNA biology and its implications in cancer and will explore the relevance of the multiple layers of RNA regulation in cancer progression as well as the opportunities they generate for cancer treatment.
 
RNA biology is a burning topic in biomedicine. Once thought of as a simple messenger between DNA and protein, it is increasingly evident that the RNA molecule and its regulation are more complex than ever anticipated, playing a major role in multiple diseases, namely cancer, and enclosing new opportunities for biomarker discovery, cancer treatment and even cancer vaccines. The development of high-throughput analytical tools has significantly contributed to our understanding of the RNA code, enabling the discovery and quantification of RNA-protein interaction events at an unprecedented resolution and scale. Translating this knowledge into the clinic will now require more functional studies, the design of stable RNA-based drugs and efficient delivery technologies.
 
As one of the most prominent cancer research events in Portugal aiming to be at the forefront of cancer research, the objective of the 30th Edition of the Porto Cancer Meeting is to bring together researchers and clinicians to provide a multidisciplinary and informal environment to share and discuss the latest advances in the role of RNA regulation in cancer biology, and its clinical implications in diagnosis, progression, and treatment. For that, we have an outstanding panel of invited speakers, selected oral communications and a poster session, which will allow ample time for discussion among participants. The main topics will include RNA processing and regulation in cancer, non-coding RNAs and cancer, RNA-binding proteins role in cancer initiation and progression, the epitranscriptome in cancer and the RNA path to the clinic.
 
We hope you will enjoy a pleasant meeting and have the opportunity to visit the beautiful and vibrant city of Porto.

**Organizing Committee**: Raquel Almeida; Bruno Pereira

### Registration and more information at [https://www.i3s.up.pt/event.php?v=301 ](link)


30th Porto Cancer Meeting
9-10 May 2024 | i3S, Porto

Porto meeting.jpg

30th Porto Cancer Meeting

 COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation. (www.cost.eu) | The TRANSLACORE Cost Action is bridging disciplines and expertise across Europe in order to advance an emerging field in cancer biology: translational control in cancer. It is providing a unique opportunity to understand this biological process leading to reconsider our view of gene expression control in this disease and deliver novel therapeutic opportunities.

Search in the Translacore

30th Porto Cancer Meeting